These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33537906)

  • 1. The impact of pneumococcal conjugate vaccine-13 on the incidence of pediatric community-acquired bacteremia.
    Dabaja-Younis H; Geller D; Geffen Y; Almog R; Kassis I
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1433-1439. PubMed ID: 33537906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced.
    Berger Y; Adler A; Ariel T; Rokney A; Averbuch D; Grisaru-Soen G
    Acta Paediatr; 2019 Jul; 108(7):1321-1328. PubMed ID: 30506762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Study of the Impact of Pneumococcal Conjugate Vaccine-13 Immunization in a Northern Israel Hospital.
    Zaitoon H; Bamberger E; Yaniv L; Mendelson B; Srugo I; Chistyakov I
    Isr Med Assoc J; 2020 Feb; 22(2):71-74. PubMed ID: 32043321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005-2012).
    Ribitzky-Eisner H; Minuhin Y; Greenberg D; Greenberg N; Chodick G; Craiu M; Leibovitz E
    Pediatr Neonatol; 2016 Oct; 57(5):378-384. PubMed ID: 26738763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines.
    Greenhow TL; Hung YY; Herz A
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28283611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization.
    Leibovitz E; David N; Ribitzky-Eisner H; Abo Madegam M; Abuabed S; Chodick G; Maimon M; Fruchtman Y
    Int J Environ Res Public Health; 2016 Jul; 13(7):. PubMed ID: 27447651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.
    Haddy RI; Perry K; Chacko CE; Helton WB; Bowling MG; Looney SW; Buck GE
    Pediatr Infect Dis J; 2005 Apr; 24(4):320-3. PubMed ID: 15818291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.
    Steenhoff AP; Shah SS; Ratner AJ; Patil SM; McGowan KL
    Clin Infect Dis; 2006 Apr; 42(7):907-14. PubMed ID: 16511752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
    Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
    Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult Bacteremia: Should We Look for the Needle in the Haystack?
    Baram N; Megged O; Weiser G
    Isr Med Assoc J; 2016 Nov; 18(11):649-651. PubMed ID: 28466611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.
    Olarte L; Lin PL; Barson WJ; Romero JR; Tan TQ; Givner LB; Hoffman JA; Bradley JS; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
    Black S; Shinefield H; Baxter R; Austrian R; Bracken L; Hansen J; Lewis E; Fireman B
    Pediatr Infect Dis J; 2004 Jun; 23(6):485-9. PubMed ID: 15194827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.
    Ben-Shimol S; Greenberg D; Givon-Lavi N; Elias N; Glikman D; Rubinstein U; Dagan R;
    Vaccine; 2012 Oct; 30(46):6600-7. PubMed ID: 22939907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.
    Jones N; Huebner R; Khoosal M; Crewe-Brown H; Klugman K
    AIDS; 1998 Nov; 12(16):2177-84. PubMed ID: 9833859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.